Company Monitoring Page for Eli-Lilly

latest headlines for company on cafepharma

AbbVie and Lilly have sent a warning signal to the UK government by leaving the voluntary medicines pricing agreement in protest over increasingly punitive revenue clawbacks
ABPI
Tue, 01/17/23 - 10:38 am
Tags:
AbbVie, Eli Lilly, UK, NHS, drug pricing
Alzheimer’s disease trials: How does Lilly’s donanemab compare to lecanemab?
Clinical Trials Arena
Fri, 01/13/23 - 10:49 am
Tags:
clinical trials, Alzheimer's disease, Eisai, Biogen, Eli Lilly, Leqembi, lecanemab, donanemab
JPM23: Amid launch spree, Eli Lilly expects revenue growth at the 'high end of the industry,' CFO says
Fierce Pharma
Thu, 01/12/23 - 10:27 am
Tags:
JPMHC 2023, Eli Lilly, pertibrutinib, donanemab, mirikizumab, lebrikizumab
Lilly, Biogen and more gear up for blockbuster launches in 2023: report
Fierce Pharma
Wed, 01/11/23 - 11:00 pm
Tags:
Clarivate, drug launches, Eli Lilly, Biogen, GSK, Bristol Myers Squibb
Eli Lilly Had a Strong Year in 2022. It's Expecting an Even Better 2023.
Motley Fool
Wed, 01/11/23 - 10:48 am
Tags:
Eli Lilly, earnings
JPM23: Lilly has a full plate, as CMO jokes, 'we need to leave J.P. Morgan and get back to work'
Fierce Biotech
Mon, 01/9/23 - 10:48 pm
Tags:
Eli Lilly, JPMHC 2023, CMOs
TRexBio Announces Collaboration and License Agreement with Lilly to Develop and Commercialize Novel Therapies for Immune-Mediated Diseases
Businesswire
Mon, 01/9/23 - 10:37 am
Tags:
Eli Lilly, TRexBio, tregs, drug development
5 FDA decisions to watch in the first quarter
BioPharma Dive
Mon, 01/9/23 - 10:27 am
Tags:
FDA, Eli Lilly, donanemab, Alzheimer's disease, Menareni, Elacestrant, breast cancer, Biomarin, Roctavian, hemophilia A, Acadia Pharmaceuticals, trofinetide, Rett Syndrome, Gilead Sciences, Trodelvy
Lilly's Prevail, Capsida partner to develop gene therapies for nervous system diseases
BioPharma Dive
Wed, 01/4/23 - 05:31 pm
Tags:
Eli Lilly, gene therapy, Capsida, CNS disorders, Prevail Therapeutics
10 clinical trials to watch in the first half of 2023
BioPharma Dive
Tue, 01/3/23 - 10:57 am
Tags:
clinical trials, Alzheimer's disease, obesity, Huntington's disease, M&A, AstraZeneca, Daiichi Sankyo, Nimbus Therapeutics, Takeda, Eli Lilly, Sanofi, Regeneron, Moderna Therapeutics, Gilead Sciences, Pfizer, Roivant, Alnylam, uniQure
Lilly, Merck double down on peptide-targeted drug delivery, betting billions in biobucks on PeptiDream pacts
Fierce Pharma
Tue, 01/3/23 - 10:10 am
Tags:
Eli Lilly, Merck, PeptiDreams, peptides, drug delivery
Could This Drug News Give a Lift to Eli Lilly Stock?
Motley Fool
Mon, 01/2/23 - 06:27 pm
Tags:
Eli Lilly, Rezvoglar, diabetes, Sanofi, Lantus, biosimilars, long-acting insulin
Lilly doubles down on ProQR's RNA tech in $75M deal expansion, spurring biotech's much-needed share rally
Fierce Biotech
Thu, 12/22/22 - 10:58 am
Tags:
Eli Lilly, ProQR Therapeutics, genetic medicine, RNA
Has This Top Pharma Company Found Its Next Billion-Dollar Product?
Motley Fool
Thu, 12/22/22 - 10:46 am
Tags:
Eli Lilly, Alzheimer's disease
Catalysts ahead for the smaller players
EP Vantage
Wed, 12/21/22 - 11:19 am
Tags:
89Bio, Altimmune, AnaptysBio, BioXcel Therapeutics, Calliditas Therapeutics, Eli Lilly, Esperion Therapeutics, Geron, Nektar Therapeutics, Oramed Pharmaceuticals, Pliant Therapeutics, Replimune, Selecta Biosciences, Swedish Orphan Biovitrum, Vera Therapeutics, Viking Therapeutics
Eli Lilly diabetes drugs Mounjaro and Trulicity in short supply, FDA says
Medical Marketing and Media
Mon, 12/19/22 - 10:17 pm
Tags:
Eli Lilly, diabetes, drug shortages, Mounjaro, Trulicity
Big pharma’s new year catalysts
EP Vantage
Mon, 12/19/22 - 11:05 am
Tags:
AstraZeneca, Daiichi Sankyo, Pfizer, Roche, CSL, uniQure, Novo Nordisk, Eli Lilly
With another FDA nod, Eagle's Pemfexy gets up to speed with Lilly's Alimta
Fierce Pharma
Mon, 12/19/22 - 11:02 am
Tags:
Eagle Pharmaceuticals, Pemfexy, Eli Lilly, mesothelioma, non-small cell lung cancer
Lilly Plunks Down up to $731M in GPCR Pact with Sosei
BioSpace
Fri, 12/16/22 - 10:27 am
Tags:
Eli Lilly, Sosei, drug discovery, drug development, diabetes, metabolic disorders
Lilly and Pfizer fight for new territory in obesity and diabetes
EP Vantage
Thu, 12/15/22 - 10:46 am
Tags:
Eli Lilly, Pfizer, obesity, diabetes, orforglipron, Mounjaro

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.